ArfGAP1 acts as a GTPase-activating protein for human ADP-ribosylation factor-like 1 protein. 2021

Hsiang-Pu Feng, and Hsiao-Yun Cheng, and Ting-Feng Hsiao, and Tai-Wei Lin, and Jia-Wei Hsu, and Lien-Hung Huang, and Chia-Jung Yu
Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

ADP-ribosylation factors (Arfs) and Arf-like (Arl) GTPases are key regulators of intracellular vesicle trafficking and Golgi structure. Both Arf and Arl proteins cycle between active GTP-bound and inactive GDP-bound forms, where guanine nucleotide exchange factors (GEFs) regulate the exchange of GDP for GTP, whereas GTPase-activating proteins (GAPs) promote the hydrolysis of bound GTP. Human Arl1 is located at the trans-Golgi network (TGN) and regulates the function and structure of the Golgi complex. However, neither GEFs nor GAPs for human Arl1 have been identified. Here, we report that ArfGAP1, an Arf1 GAP, can promote GTP hydrolysis of Arl1. We show that ArfGAP1 directly interacts with GTP-bound Arl1 and exhibits GAP activity toward Arl1 in vitro. Exogenous expression of ArfGAP1, but not ArfGAP2 and ArfGAP3, causes dissociation of endogenous Arl1 from the TGN. In addition, GAP activity-deficient ArfGAP1 fails to regulate the Golgi localization of Arl1. Using an activity pull-down assay, we demonstrated that ArfGAP1 regulates the levels of Arl1-GTP in cells expressing ArfGAP1-myc or with ArfGAP1 knockdown. Finally, we observed that, similar to expression of putative active Arl1 (Arl1QL), ArfGAP1 knockdown impairs endosome-to-TGN retrograde transport of the Shiga toxin B-subunit. Thus, our findings support the idea that ArfGAP1 acts as an Arl1 GAP to regulate the function of Arl1 in vesicle trafficking at the TGN.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006056 Golgi Apparatus A stack of flattened vesicles that functions in posttranslational processing and sorting of proteins, receiving them from the rough ENDOPLASMIC RETICULUM and directing them to secretory vesicles, LYSOSOMES, or the CELL MEMBRANE. The movement of proteins takes place by transfer vesicles that bud off from the rough endoplasmic reticulum or Golgi apparatus and fuse with the Golgi, lysosomes or cell membrane. (From Glick, Glossary of Biochemistry and Molecular Biology, 1990) Golgi Complex,Apparatus, Golgi,Complex, Golgi
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074744 ADP-Ribosylation Post-translational modification of proteins with ADENOSINE DIPHOSPHATE RIBOSE. (ADP-Ribosyl)ation,(ADPRibosyl)ation,ADP Ribosylation,ADPRibosylation,MARylation,Mono ADPRibosylation,Mono(ADP-Ribosyl)ation,Mono(ADPRibosyl)ation,Mono-ADP-Ribosylation,Mono-ADPRibosylation,MonoADPRibosylation,ADP Ribosylations,ADP-Ribosylations,ADPRibosylation, Mono,ADPRibosylations,ADPRibosylations, Mono,MARylations,Mono ADP Ribosylation,Mono ADPRibosylations,Mono-ADP-Ribosylations,Mono-ADPRibosylations,MonoADPRibosylations,Ribosylation, ADP,Ribosylations, ADP
D020558 GTP Phosphohydrolases Enzymes that hydrolyze GTP to GDP. EC 3.6.1.-. GTPase,GTPases,Guanosine Triphosphate Phosphohydrolases,Guanosinetriphosphatases,GTP Phosphohydrolase,Phosphohydrolase, GTP,Phosphohydrolases, GTP,Phosphohydrolases, Guanosine Triphosphate,Triphosphate Phosphohydrolases, Guanosine
D020690 GTPase-Activating Proteins Proteins that activate the GTPase of specific GTP-BINDING PROTEINS. GAP Proteins,GAP Protein,GTPase-Activating Protein,GTPase Activating Protein,GTPase Activating Proteins
D020727 ADP-Ribosylation Factors MONOMERIC GTP-BINDING PROTEINS that were initially recognized as allosteric activators of the MONO(ADP-RIBOSE) TRANSFERASE of the CHOLERA TOXIN catalytic subunit. They are involved in vesicle trafficking and activation of PHOSPHOLIPASE D. This enzyme was formerly listed as EC 3.6.1.47 ADP-Ribosylation Factor,ARF Protein Cofactor,ADP Ribosylation Factor,ADP Ribosylation Factors
D021381 Protein Transport The process of moving proteins from one cellular compartment (including extracellular) to another by various sorting and transport mechanisms such as gated transport, protein translocation, and vesicular transport. Cellular Protein Targeting,Gated Protein Transport,Protein Targeting, Cellular,Protein Translocation,Transmembrane Protein Transport,Vesicular Protein Transport,Protein Localization Processes, Cellular,Protein Sorting,Protein Trafficking,Protein Transport, Gated,Protein Transport, Transmembrane,Protein Transport, Vesicular,Traffickings, Protein

Related Publications

Hsiang-Pu Feng, and Hsiao-Yun Cheng, and Ting-Feng Hsiao, and Tai-Wei Lin, and Jia-Wei Hsu, and Lien-Hung Huang, and Chia-Jung Yu
December 1997, The Journal of biological chemistry,
Hsiang-Pu Feng, and Hsiao-Yun Cheng, and Ting-Feng Hsiao, and Tai-Wei Lin, and Jia-Wei Hsu, and Lien-Hung Huang, and Chia-Jung Yu
January 2001, Methods in enzymology,
Hsiang-Pu Feng, and Hsiao-Yun Cheng, and Ting-Feng Hsiao, and Tai-Wei Lin, and Jia-Wei Hsu, and Lien-Hung Huang, and Chia-Jung Yu
September 1996, Proceedings of the National Academy of Sciences of the United States of America,
Hsiang-Pu Feng, and Hsiao-Yun Cheng, and Ting-Feng Hsiao, and Tai-Wei Lin, and Jia-Wei Hsu, and Lien-Hung Huang, and Chia-Jung Yu
March 1995, The Journal of biological chemistry,
Hsiang-Pu Feng, and Hsiao-Yun Cheng, and Ting-Feng Hsiao, and Tai-Wei Lin, and Jia-Wei Hsu, and Lien-Hung Huang, and Chia-Jung Yu
January 1998, The Journal of biological chemistry,
Hsiang-Pu Feng, and Hsiao-Yun Cheng, and Ting-Feng Hsiao, and Tai-Wei Lin, and Jia-Wei Hsu, and Lien-Hung Huang, and Chia-Jung Yu
April 1994, The Journal of biological chemistry,
Hsiang-Pu Feng, and Hsiao-Yun Cheng, and Ting-Feng Hsiao, and Tai-Wei Lin, and Jia-Wei Hsu, and Lien-Hung Huang, and Chia-Jung Yu
January 2000, Memorias do Instituto Oswaldo Cruz,
Hsiang-Pu Feng, and Hsiao-Yun Cheng, and Ting-Feng Hsiao, and Tai-Wei Lin, and Jia-Wei Hsu, and Lien-Hung Huang, and Chia-Jung Yu
June 2005, Molecular pharmacology,
Hsiang-Pu Feng, and Hsiao-Yun Cheng, and Ting-Feng Hsiao, and Tai-Wei Lin, and Jia-Wei Hsu, and Lien-Hung Huang, and Chia-Jung Yu
June 1997, The Biochemical journal,
Hsiang-Pu Feng, and Hsiao-Yun Cheng, and Ting-Feng Hsiao, and Tai-Wei Lin, and Jia-Wei Hsu, and Lien-Hung Huang, and Chia-Jung Yu
May 1999, European journal of cell biology,
Copied contents to your clipboard!